Suggested Topics within your search.
Showing 2,681 - 2,700 results of 2,982 for search 'show trial', query time: 0.09s Refine Results
  1. 2681

    Benefits and Risks of Clopidogrel vs. Aspirin Monotherapy after Recent Ischemic Stroke: A Systematic Review and Meta-Analysis by Maurizio Paciaroni, Birsen Ince, Bo Hu, Jiann-Shing Jeng, Kursad Kutluk, Liping Liu, Min Lou, Vladimir Parfenov, Ka Sing Lawrence Wong, Babak Zamani, Dara Paek, Jung Min Han, Michael del Aguila, Shalini Girotra

    Published 2019-01-01
    “…Conclusions. The analysis showed lower risks of major adverse cardiovascular or cerebrovascular events, recurrent stroke, and bleeding events for clopidogrel monotherapy compared to aspirin. …”
    Get full text
    Article
  2. 2682
  3. 2683
  4. 2684

    A Comprehensive Analysis of Moist Versus Non‐Moist Dressings for Split‐Thickness Skin Graft Donor Sites: A Systematic Review and Meta‐Analysis by Chun‐Yee Ho, Hsuan‐Yu Chou, Szu‐Han Wang, Ching‐Yu Lan, Victor Bong‐Hang Shyu, Chih‐Hao Chen, Chia‐Hsuan Tsai

    Published 2025-01-01
    “…Moist dressings such as Tegaderm, Hydrocolloid, Alginate, polyurethane, and hydrofiber showed a faster mean time to healing compared to non‐moist dressings like Mepitel and paraffin‐impregnated gauze. …”
    Get full text
    Article
  5. 2685
  6. 2686

    Targeted Therapies Compared to Dacarbazine for Treatment of BRAFV600E Metastatic Melanoma: A Cost-Effectiveness Analysis by Vanessa Shih, Renske M. ten Ham, Christine T. Bui, Dan N. Tran, Jie Ting, Leslie Wilson

    Published 2015-01-01
    “…Transition probabilities were derived from two Phase III registration trials comparing each BRAF inhibitor against dacarbazine. …”
    Get full text
    Article
  7. 2687

    Feasibility and potential effect of a pilot blended digital behavior change intervention promoting sustainable diets over a year by Ujué Fresán, Miguel López-Moreno, Sergi Fàbregues, Paquito Bernard, Anna Boronat, Vera Araújo-Soares, Laura M. König, Joren Buekers, Guillaume Chevance

    Published 2025-01-01
    “…We conducted a series of ABA n-of-1 trials with baseline, intervention, and follow-up phases over the course of a year, involving twelve participants. …”
    Get full text
    Article
  8. 2688
  9. 2689

    Acquired vulnerability against EGF receptor inhibition in gastric cancer promoted by class I histone deacetylase inhibitor entinostat by Tamara Zenz, Robert Jenke, Denys Oliinyk, Sandra Noske, René Thieme, Tim Kahl, Ines Gockel, Florian Meier-Rosar, Achim Aigner, Thomas RH Büch

    Published 2025-02-01
    “…Introduction: Histone deacetylase inhibitors (HDACi) have shown promising preclinical activity in gastric cancer cells; unfortunately, however, these could not be confirmed in clinical trials. This highlights the need for the identification of underlying reasons, which may also provide the basis for possible combination therapies. …”
    Get full text
    Article
  10. 2690
  11. 2691

    Discovery of a non‐nucleotide stimulator of interferon genes (STING) agonist with systemic antitumor effect by Xiyuan Wang, Zhengsheng Zhan, Zhen Wang, Yan Zhang, Kaiyan Zhao, Han Li, Xiaoqian Zhou, Yuting Guo, Fengying Fan, Jian Ding, Meiyu Geng, Xuekui Yu, Wenhu Duan, Zuoquan Xie

    Published 2025-01-01
    “…Herein, we developed and identified a non‐nucleotide STING agonist called DW18343. DW18343 showed robust activation across different STING isoforms. …”
    Get full text
    Article
  12. 2692

    Stemness Maintenance Properties in Human Oral Stem Cells after Long-Term Passage by Francesca Diomede, Thangavelu Soundara Rajan, Valentina Gatta, Marco D’Aurora, Ilaria Merciaro, Marco Marchisio, Aurelio Muttini, Sergio Caputi, Placido Bramanti, Emanuela Mazzon, Oriana Trubiani

    Published 2017-01-01
    “…Cell proliferation assay showed no difference between early and late passages while senescence markers p16 and p21 were considerably increased in late passage. …”
    Get full text
    Article
  13. 2693

    Comparison of the risk of obesity in the FTO rs9939609 genotype in a multiethnic group in Asia systematic review and meta-analysis by Donna Pratiwi, Miko Sidartha, Elvan Wiyarta, Elvan Wiyarta, I Wayan Agustinus Harimawan, Ni Made Dwi Asti Lestari, Bonglee Kim, Nurpudji Astuti Taslim, Trina Ekawati Tallei, Fahrul Nurkolis, Rony Abdi Syahputra

    Published 2025-02-01
    “…Review Manager (RevMan) 5.4.1 were used to analyze the data.ResultsFrom 18 studies, the results of the dominant genetic model AA vs. TT showed POR 95%Cl = 1.95 (1.36–2.80); p < 0.00001, in AA vs. …”
    Get full text
    Article
  14. 2694
  15. 2695

    Using Health Utility Index (HUI) for Measuring the Impact on Health-Related Quality of Life (HRQL) Among Individuals with Chronic Diseases by Frank Mo, Bernard C.K. Choi, Felix C.K. Li, Joav Merrick

    Published 2004-01-01
    “…Logistic Regression results showed a strong relationship between low HUI scores (≤ 0.5 and 0.06–1.0) and certain chronic conditions. …”
    Get full text
    Article
  16. 2696

    Meta-analysis of MitraClip and PASCAL for transcatheter mitral edge-to-edge repair by Mahmoud Balata, Mohamed Ibrahim Gbreel, Mohamed Hamouda Elkasaby, Marwa Hassan, Marc Ulrich Becher

    Published 2025-01-01
    “…Conclusion MitraClip and PASCAL devices showed comparable safety profiles and procedural success rates. …”
    Get full text
    Article
  17. 2697

    Movement Competency Screens Can Be Reliable In Clinical Practice By A Single Rater Using The Composite Score by Kerry J. Mann, Nicholas O'Dwyer, Michaela R. Bruton, Stephen P. Bird, Suzi Edwards

    Published 2022-06-01
    “…While athletes did not display a familiarization effect after performing the novel tasks within the MCS for the first time, raters showed improved error detection on repeated viewing of the same movement…”
    Get full text
    Article
  18. 2698
  19. 2699

    Artificial Taste: Advances and Innovative Applications in Healthcare by Letao Wang, Yuzhang Li, Yao Zhang, Bin Zheng

    Published 2025-01-01
    “…Only six studies reported verification results, showing that most participants perceived sour and salty tastes, mild bitter responses, and unreliable sweet evocation. …”
    Get full text
    Article
  20. 2700

    Rifaximin versus Nonabsorbable Disaccharides for the Treatment of Hepatic Encephalopathy: A Meta-Analysis by Dong Wu, Shu-Mei Wu, Jie Lu, Ying-Qun Zhou, Ling Xu, Chuan-Yong Guo

    Published 2013-01-01
    “…A total of 8 randomized controlled trials including 407 patients were included. The efficacy of rifaximin was equivalent to nonabsorbable disaccharides according to the statistical data (risk ratio (RR): 1.06, 95% CI: 0.94–1.19; P=0.34). …”
    Get full text
    Article